Scientists have reached a breakthrough in treating diabetes. Scientists have conducted a number of tests that show it is possible to restore natural insulin production for as much as a year by boosting the immune system. For diabetic patients, this means an end to using insulin injections on a daily basis is quite near. Reportedly, Pakistan has the seventh highest number of diabetics in the world. Around 7.1 million people suffer from diabetes in Pakistan. Majority of these people need to inject themselves with insulin on a daily basis to keep their blood sugars in check.
Diabetes attack cells that secrete insulin in the pancreas. A healthy person would have billions of cells referred to as ‘T-regs’. T-regs protect cells that secrete insulin. People suffering from diabetes do not have enough of these cells. Researchers at the University of California and Yale successfully removed T-regs from the body, increase their quantity by 1,500x, and infused them back into the bloodstream successfully restoring normal function. An initial trial of 14 different people showed that this particular method is safe and can last up to a year. This treatment not only prevents regular injections, but also keeps the disease from progressing further. Diabetes, if left unattended can lead to blindness, amputation and several other issues. The first 14 patients to undergo this treatment were aged between 18 and 43. All the patients were satisfied with the process and showed amazing signs of recovery.
The team responsible for this research stated that not only is the treatment effective against diabetes, but it can further help with other autoimmune diseases including rheumatoid arthritis, neurological and cardiovascular diseases, and obesity. Diabetes is one of the strongly prevailing diseases in the world. Such a breakthrough brings hopes to millions and millions around the world. Hopefully, upon progress, the treatment is refined and commercialized.
This research was published in the journal Science Translational MedicineYou can follow us on Facebook, Twitter, or Google+ for more updates. Otherwise fill in the subscription box above, or subscribe to our RSS Feed.